Application of the IDSA Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients: Impact on Reducing the Use of Glycopeptides
- 1 October 2001
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (10) , 651-653
- https://doi.org/10.1086/501839
Abstract
We evaluated the impact of applying the Infectious Diseases Society of America guidelines for febrile neutropenic patients in reducing the use of glycopeptides. Forty-five prior episodes of febrile neutropenia were compared to 97 episodes seen after application of the guidelines. Glycopeptide use was reduced from 73% to 43% of episodes (P=.0008), without changes in outcome.Keywords
This publication has 7 references indexed in Scilit:
- Vancomycin‐ResistantStaphylococcus aureus: Infection Control ConsiderationsClinical Infectious Diseases, 1998
- Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.Journal of Clinical Oncology, 1998
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Risk Factors Associated with Vancomycin-Resistant Enterococcus faecium Infection or Colonization in 145 Matched Case Patients and Control PatientsClinical Infectious Diseases, 1996
- Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-AnalysisClinical Infectious Diseases, 1996
- Risk Factors for Candidemia in Patients with Acute Lymphocytic LeukemiaClinical Infectious Diseases, 1991
- Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxisThe American Journal of Medicine, 1990